皮下免疫グロブリンのグローバル市場2021

• 英文タイトル：Global Subcutaneous Immunoglobulins Sales Market Report 2021

• レポートコード：QAF27899
• 出版社/出版日：QYResearch / 2021年3月31日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、137ページ
• 納品方法：Eメール（即日納品）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥600,000 (USD4,000)	▷ お問い合わせ
Multi User	￥900,000 (USD6,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

本市場調査資料では、世界の皮下免疫グロブリン市場について種類別（0.1、0.2）、用途別（原発性免疫不全症、二次性免疫不全症、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・皮下免疫グロブリン市場の概要
・世界の主要地域別皮下免疫グロブリン市場規模2016-2027
・主要プレイヤーの競争状況・市場シェア
・世界の皮下免疫グロブリン市場規模2016-2021：種類別（0.1、0.2）
・世界の皮下免疫グロブリン市場予測2012-2027：種類別（0.1、0.2）
・世界の皮下免疫グロブリン市場規模2016-2021：用途別（原発性免疫不全症、二次性免疫不全症、その他）
・世界の皮下免疫グロブリン市場予測2012-2027：用途別（原発性免疫不全症、二次性免疫不全症、その他）
・皮下免疫グロブリンのアメリカ市場規模と予測2016-2021
・皮下免疫グロブリンのヨーロッパ市場規模と予測2016-2021
・皮下免疫グロブリンの中国市場規模と予測2016-2021
・皮下免疫グロブリンの日本市場規模と予測2016-2021
・皮下免疫グロブリンの東南アジア市場規模と予測2016-2021
・皮下免疫グロブリンのインド市場規模と予測2016-2021
・主要プレイヤーの企業情報：事業概要・売上・企業動向
（Shire (Baxalta)、Grifols、CSL）
・皮下免疫グロブリンの製造コスト分析
・販売チャネル、流通業者、顧客
・皮下免疫グロブリンの市場動向・機会・課題
・調査の結論

Subcutaneous Immunoglobulin (SCIg) infusions are administered by slowly injecting purified immunoglobulin into fatty tissue underneath the skin. SCIg can be administered at home by patients or carers, using an infusion pump (spring loaded or battery powered) or by rapid push (a manual method that does not require a pump).
The classification of subcutaneous immunoglobulins includes 10% purity and 20% purity, and in U.S. the proportion of 10% purity in 2016 is about 70%, and the proportion is in decreasing trend from 2012 to 2016.

Market Analysis and Insights: Global Subcutaneous Immunoglobulins Market
The global Subcutaneous Immunoglobulins market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Subcutaneous Immunoglobulins Scope and Market Size
The global Subcutaneous Immunoglobulins market is segmented by company, region (country), by Purity, and by Application. Players, stakeholders, and other participants in the global Subcutaneous Immunoglobulins market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Purity and by Application for the period 2016-2027.

Segment by Purity
0.1
0.2

Segment by Application
Primary Immunodeficiency
Secondary Immunodeficiency
Others

The Subcutaneous Immunoglobulins market is analysed and market size information is provided by regions (countries). Segment by Application, the Subcutaneous Immunoglobulins market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Shire (Baxalta)
Grifols
CSL

レポート目次

1 Subcutaneous Immunoglobulins Market Overview
1.1 Subcutaneous Immunoglobulins Product Scope
1.2 Subcutaneous Immunoglobulins Segment by Purity
1.2.1 Global Subcutaneous Immunoglobulins Sales by Purity (2016 & 2021 & 2027)
1.2.2 0.1
1.2.3 0.2
1.3 Subcutaneous Immunoglobulins Segment by Application
1.3.1 Global Subcutaneous Immunoglobulins Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Primary Immunodeficiency
1.3.3 Secondary Immunodeficiency
1.3.4 Others
1.4 Subcutaneous Immunoglobulins Market Estimates and Forecasts (2016-2027)
1.4.1 Global Subcutaneous Immunoglobulins Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Subcutaneous Immunoglobulins Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Subcutaneous Immunoglobulins Price Trends (2016-2027)

2 Subcutaneous Immunoglobulins Estimates and Forecasts by Region
2.1 Global Subcutaneous Immunoglobulins Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Subcutaneous Immunoglobulins Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Subcutaneous Immunoglobulins Sales Market Share by Region (2016-2021)
2.2.2 Global Subcutaneous Immunoglobulins Revenue Market Share by Region (2016-2021)
2.3 Global Subcutaneous Immunoglobulins Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Subcutaneous Immunoglobulins Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Subcutaneous Immunoglobulins Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Subcutaneous Immunoglobulins Estimates and Projections (2016-2027)
2.4.2 Europe Subcutaneous Immunoglobulins Estimates and Projections (2016-2027)
2.4.3 China Subcutaneous Immunoglobulins Estimates and Projections (2016-2027)
2.4.4 Japan Subcutaneous Immunoglobulins Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Subcutaneous Immunoglobulins Estimates and Projections (2016-2027)
2.4.6 India Subcutaneous Immunoglobulins Estimates and Projections (2016-2027)
3 Global Subcutaneous Immunoglobulins Competition Landscape by Players
3.1 Global Top Subcutaneous Immunoglobulins Players by Sales (2016-2021)
3.2 Global Top Subcutaneous Immunoglobulins Players by Revenue (2016-2021)
3.3 Global Subcutaneous Immunoglobulins Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Subcutaneous Immunoglobulins as of 2020)
3.4 Global Subcutaneous Immunoglobulins Average Price by Company (2016-2021)
3.5 Manufacturers Subcutaneous Immunoglobulins Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Subcutaneous Immunoglobulins Market Size by Purity
4.1 Global Subcutaneous Immunoglobulins Historic Market Review by Purity (2016-2021)
4.1.1 Global Subcutaneous Immunoglobulins Sales Market Share by Purity (2016-2021)
4.1.2 Global Subcutaneous Immunoglobulins Revenue Market Share by Purity (2016-2021)
4.1.3 Global Subcutaneous Immunoglobulins Price by Purity (2016-2021)
4.2 Global Subcutaneous Immunoglobulins Market Estimates and Forecasts by Purity (2022-2027)
4.2.1 Global Subcutaneous Immunoglobulins Sales Forecast by Purity (2022-2027)
4.2.2 Global Subcutaneous Immunoglobulins Revenue Forecast by Purity (2022-2027)
4.2.3 Global Subcutaneous Immunoglobulins Price Forecast by Purity (2022-2027)
5 Global Subcutaneous Immunoglobulins Market Size by Application
5.1 Global Subcutaneous Immunoglobulins Historic Market Review by Application (2016-2021)
5.1.1 Global Subcutaneous Immunoglobulins Sales Market Share by Application (2016-2021)
5.1.2 Global Subcutaneous Immunoglobulins Revenue Market Share by Application (2016-2021)
5.1.3 Global Subcutaneous Immunoglobulins Price by Application (2016-2021)
5.2 Global Subcutaneous Immunoglobulins Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Subcutaneous Immunoglobulins Sales Forecast by Application (2022-2027)
5.2.2 Global Subcutaneous Immunoglobulins Revenue Forecast by Application (2022-2027)
5.2.3 Global Subcutaneous Immunoglobulins Price Forecast by Application (2022-2027)

6 North America Subcutaneous Immunoglobulins Market Facts & Figures
6.1 North America Subcutaneous Immunoglobulins Sales by Company
6.1.1 North America Subcutaneous Immunoglobulins Sales by Company (2016-2021)
6.1.2 North America Subcutaneous Immunoglobulins Revenue by Company (2016-2021)
6.2 North America Subcutaneous Immunoglobulins Sales Breakdown by Purity
6.2.1 North America Subcutaneous Immunoglobulins Sales Breakdown by Purity (2016-2021)
6.2.2 North America Subcutaneous Immunoglobulins Sales Breakdown by Purity (2022-2027)
6.3 North America Subcutaneous Immunoglobulins Sales Breakdown by Application
6.3.1 North America Subcutaneous Immunoglobulins Sales Breakdown by Application (2016-2021)
6.3.2 North America Subcutaneous Immunoglobulins Sales Breakdown by Application (2022-2027)

7 Europe Subcutaneous Immunoglobulins Market Facts & Figures
7.1 Europe Subcutaneous Immunoglobulins Sales by Company
7.1.1 Europe Subcutaneous Immunoglobulins Sales by Company (2016-2021)
7.1.2 Europe Subcutaneous Immunoglobulins Revenue by Company (2016-2021)
7.2 Europe Subcutaneous Immunoglobulins Sales Breakdown by Purity
7.2.1 Europe Subcutaneous Immunoglobulins Sales Breakdown by Purity (2016-2021)
7.2.2 Europe Subcutaneous Immunoglobulins Sales Breakdown by Purity (2022-2027)
7.3 Europe Subcutaneous Immunoglobulins Sales Breakdown by Application
7.3.1 Europe 137 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 137 Sales Breakdown by Application (2022-2027)

8 China Subcutaneous Immunoglobulins Market Facts & Figures
8.1 China Subcutaneous Immunoglobulins Sales by Company
8.1.1 China Subcutaneous Immunoglobulins Sales by Company (2016-2021)
8.1.2 China Subcutaneous Immunoglobulins Revenue by Company (2016-2021)
8.2 China Subcutaneous Immunoglobulins Sales Breakdown by Purity
8.2.1 China Subcutaneous Immunoglobulins Sales Breakdown by Purity (2016-2021)
8.2.2 China Subcutaneous Immunoglobulins Sales Breakdown by Purity (2022-2027)
8.3 China Subcutaneous Immunoglobulins Sales Breakdown by Application
8.3.1 China 246 Sales Breakdown by Application (2016-2021)
8.3.2 China 246 Sales Breakdown by Application (2022-2027)

9 Japan Subcutaneous Immunoglobulins Market Facts & Figures
9.1 Japan Subcutaneous Immunoglobulins Sales by Company
9.1.1 Japan Subcutaneous Immunoglobulins Sales by Company (2016-2021)
9.1.2 Japan Subcutaneous Immunoglobulins Revenue by Company (2016-2021)
9.2 Japan Subcutaneous Immunoglobulins Sales Breakdown by Purity
9.2.1 Japan Subcutaneous Immunoglobulins Sales Breakdown by Purity (2016-2021)
9.2.2 Japan Subcutaneous Immunoglobulins Sales Breakdown by Purity (2022-2027)
9.3 Japan Subcutaneous Immunoglobulins Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Subcutaneous Immunoglobulins Market Facts & Figures
10.1 Southeast Asia Subcutaneous Immunoglobulins Sales by Company
10.1.1 Southeast Asia Subcutaneous Immunoglobulins Sales by Company (2016-2021)
10.1.2 Southeast Asia Subcutaneous Immunoglobulins Revenue by Company (2016-2021)
10.2 Southeast Asia Subcutaneous Immunoglobulins Sales Breakdown by Purity
10.2.1 Southeast Asia Subcutaneous Immunoglobulins Sales Breakdown by Purity (2016-2021)
10.2.2 Southeast Asia Subcutaneous Immunoglobulins Sales Breakdown by Purity (2022-2027)
10.3 Southeast Asia Subcutaneous Immunoglobulins Sales Breakdown by Application
10.3.1 Southeast Asia K Bottle Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Bottle Sales Breakdown by Application (2022-2027)

11 India Subcutaneous Immunoglobulins Market Facts & Figures
11.1 India Subcutaneous Immunoglobulins Sales by Company
11.1.1 India Subcutaneous Immunoglobulins Sales by Company (2016-2021)
11.1.2 India Subcutaneous Immunoglobulins Revenue by Company (2016-2021)
11.2 India Subcutaneous Immunoglobulins Sales Breakdown by Purity
11.2.1 India Subcutaneous Immunoglobulins Sales Breakdown by Purity (2016-2021)
11.2.2 India Subcutaneous Immunoglobulins Sales Breakdown by Purity (2022-2027)
11.3 India Subcutaneous Immunoglobulins Sales Breakdown by Application
11.3.1 India Subcutaneous Immunoglobulins Sales Breakdown by Application (2016-2021)
11.3.2 India Subcutaneous Immunoglobulins Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Subcutaneous Immunoglobulins Business
12.1 Shire (Baxalta)
12.1.1 Shire (Baxalta) Corporation Information
12.1.2 Shire (Baxalta) Business Overview
12.1.3 Shire (Baxalta) Subcutaneous Immunoglobulins Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Shire (Baxalta) Subcutaneous Immunoglobulins Products Offered
12.1.5 Shire (Baxalta) Recent Development
12.2 Grifols
12.2.1 Grifols Corporation Information
12.2.2 Grifols Business Overview
12.2.3 Grifols Subcutaneous Immunoglobulins Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Grifols Subcutaneous Immunoglobulins Products Offered
12.2.5 Grifols Recent Development
12.3 CSL
12.3.1 CSL Corporation Information
12.3.2 CSL Business Overview
12.3.3 CSL Subcutaneous Immunoglobulins Sales, Revenue and Gross Margin (2016-2021)
12.3.4 CSL Subcutaneous Immunoglobulins Products Offered
12.3.5 CSL Recent Development
…

13 Subcutaneous Immunoglobulins Manufacturing Cost Analysis
13.1 Subcutaneous Immunoglobulins Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Subcutaneous Immunoglobulins
13.4 Subcutaneous Immunoglobulins Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Subcutaneous Immunoglobulins Distributors List
14.3 Subcutaneous Immunoglobulins Customers

15 Market Dynamics
15.1 Subcutaneous Immunoglobulins Market Trends
15.2 Subcutaneous Immunoglobulins Drivers
15.3 Subcutaneous Immunoglobulins Market Challenges
15.4 Subcutaneous Immunoglobulins Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Subcutaneous Immunoglobulins Sales (US$ Million) Growth Rate by Purity (2016 & 2021 & 2027)
Table 2. Global Subcutaneous Immunoglobulins Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Subcutaneous Immunoglobulins Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Subcutaneous Immunoglobulins Sales (K Bottle) by Region (2016-2021)
Table 5. Global Subcutaneous Immunoglobulins Sales Market Share by Region (2016-2021)
Table 6. Global Subcutaneous Immunoglobulins Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Subcutaneous Immunoglobulins Revenue Share by Region (2016-2021)
Table 8. Global Subcutaneous Immunoglobulins Sales (K Bottle) Forecast by Region (2022-2027)
Table 9. Global Subcutaneous Immunoglobulins Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Subcutaneous Immunoglobulins Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Subcutaneous Immunoglobulins Revenue Share Forecast by Region (2022-2027)
Table 12. Global Subcutaneous Immunoglobulins Sales (K Bottle) of Key Companies (2016-2021)
Table 13. Global Subcutaneous Immunoglobulins Sales Share by Company (2016-2021)
Table 14. Global Subcutaneous Immunoglobulins Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Subcutaneous Immunoglobulins Revenue Share by Company (2016-2021)
Table 16. Global Subcutaneous Immunoglobulins by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Subcutaneous Immunoglobulins as of 2020)
Table 17. Global Subcutaneous Immunoglobulins Average Price (USD/Bottle) of Key Company (2016-2021)
Table 18. Manufacturers Subcutaneous Immunoglobulins Manufacturing Sites and Area Served
Table 19. Manufacturers Subcutaneous Immunoglobulins Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Subcutaneous Immunoglobulins Sales (K Bottle) by Purity (2016-2021)
Table 22. Global Subcutaneous Immunoglobulins Sales Share by Purity (2016-2021)
Table 23. Global Subcutaneous Immunoglobulins Revenue (US$ Million) Market Share by Purity (2016-2021)
Table 24. Global Subcutaneous Immunoglobulins Price (USD/Bottle) by Purity (2016-2021)
Table 25. Global Subcutaneous Immunoglobulins Sales Share by Purity (2022-2027)
Table 26. Global Subcutaneous Immunoglobulins Revenue (US$ Million) Market Share by Purity (2022-2027)
Table 27. Global Subcutaneous Immunoglobulins Revenue Share by Purity (2022-2027)
Table 28. Global Subcutaneous Immunoglobulins Price (USD/Bottle) by Purity (2022-2027)
Table 29. Global Subcutaneous Immunoglobulins Sales (K Bottle) by Application (2016-2021)
Table 30. Global Subcutaneous Immunoglobulins Sales Share by Application (2016-2021)
Table 31. Global Subcutaneous Immunoglobulins Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Subcutaneous Immunoglobulins Price (USD/Bottle) by Application (2016-2021)
Table 33. Global Subcutaneous Immunoglobulins Sales (K Bottle) by Application (2022-2027)
Table 34. Global Subcutaneous Immunoglobulins Sales Share by Application (2022-2027)
Table 35. Global Subcutaneous Immunoglobulins Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Subcutaneous Immunoglobulins Revenue Share by Application (2022-2027)
Table 37. Global Subcutaneous Immunoglobulins Price (USD/Bottle) by Application (2022-2027)
Table 38. North America Subcutaneous Immunoglobulins Sales (K Bottle) by Company (2016-2021)
Table 39. North America Subcutaneous Immunoglobulins Sales Market Share by Company (2016-2021)
Table 40. North America Subcutaneous Immunoglobulins Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Subcutaneous Immunoglobulins Revenue Market Share by Company (2016-2021)
Table 42. North America Subcutaneous Immunoglobulins Sales by Purity (2016-2021) & (K Bottle)
Table 43. North America Subcutaneous Immunoglobulins Sales Market Share by Purity (2016-2021)
Table 44. North America Subcutaneous Immunoglobulins Sales by Purity (2022-2027) & (K Bottle)
Table 45. North America Subcutaneous Immunoglobulins Sales Market Share by Purity (2022-2027)
Table 46. North America Subcutaneous Immunoglobulins Sales by Application (2016-2021) & (K Bottle)
Table 47. North America Subcutaneous Immunoglobulins Sales Market Share by Application (2016-2021)
Table 48. North America Subcutaneous Immunoglobulins Sales by Application (2022-2027) & (K Bottle)
Table 49. North America Subcutaneous Immunoglobulins Sales Market Share by Application (2022-2027)
Table 50. Europe Subcutaneous Immunoglobulins Sales (K Bottle) by Company (2016-2021)
Table 51. Europe Subcutaneous Immunoglobulins Sales Market Share by Company (2016-2021)
Table 52. Europe Subcutaneous Immunoglobulins Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Subcutaneous Immunoglobulins Revenue Market Share by Company (2016-2021)
Table 54. Europe Subcutaneous Immunoglobulins Sales by Purity (2016-2021) & (K Bottle)
Table 55. Europe Subcutaneous Immunoglobulins Sales Market Share by Purity (2016-2021)
Table 56. Europe Subcutaneous Immunoglobulins Sales by Purity (2022-2027) & (K Bottle)
Table 57. Europe Subcutaneous Immunoglobulins Sales Market Share by Purity (2022-2027)
Table 58. Europe Subcutaneous Immunoglobulins Sales by Application (2016-2021) & (K Bottle)
Table 59. Europe Subcutaneous Immunoglobulins Sales Market Share by Application (2016-2021)
Table 60. Europe Subcutaneous Immunoglobulins Sales by Application (2022-2027) & (K Bottle)
Table 61. Europe Subcutaneous Immunoglobulins Sales Market Share by Application (2022-2027)
Table 62. China Subcutaneous Immunoglobulins Sales (K Bottle) by Company (2016-2021)
Table 63. China Subcutaneous Immunoglobulins Sales Market Share by Company (2016-2021)
Table 64. China Subcutaneous Immunoglobulins Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Subcutaneous Immunoglobulins Revenue Market Share by Company (2016-2021)
Table 66. China Subcutaneous Immunoglobulins Sales by Purity (2016-2021) & (K Bottle)
Table 67. China Subcutaneous Immunoglobulins Sales Market Share by Purity (2016-2021)
Table 68. China Subcutaneous Immunoglobulins Sales by Purity (2022-2027) & (K Bottle)
Table 69. China Subcutaneous Immunoglobulins Sales Market Share by Purity (2022-2027)
Table 70. China Subcutaneous Immunoglobulins Sales by Application (2016-2021) & (K Bottle)
Table 71. China Subcutaneous Immunoglobulins Sales Market Share by Application (2016-2021)
Table 72. China Subcutaneous Immunoglobulins Sales by Application (2022-2027) & (K Bottle)
Table 73. China Subcutaneous Immunoglobulins Sales Market Share by Application (2022-2027)
Table 74. Japan Subcutaneous Immunoglobulins Sales (K Bottle) by Company (2016-2021)
Table 75. Japan Subcutaneous Immunoglobulins Sales Market Share by Company (2016-2021)
Table 76. Japan Subcutaneous Immunoglobulins Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Subcutaneous Immunoglobulins Revenue Market Share by Company (2016-2021)
Table 78. Japan Subcutaneous Immunoglobulins Sales by Purity (2016-2021) & (K Bottle)
Table 79. Japan Subcutaneous Immunoglobulins Sales Market Share by Purity (2016-2021)
Table 80. Japan Subcutaneous Immunoglobulins Sales by Purity (2022-2027) & (K Bottle)
Table 81. Japan Subcutaneous Immunoglobulins Sales Market Share by Purity (2022-2027)
Table 82. Japan Subcutaneous Immunoglobulins Sales by Application (2016-2021) & (K Bottle)
Table 83. Japan Subcutaneous Immunoglobulins Sales Market Share by Application (2016-2021)
Table 84. Japan Subcutaneous Immunoglobulins Sales by Application (2022-2027) & (K Bottle)
Table 85. Japan Subcutaneous Immunoglobulins Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Subcutaneous Immunoglobulins Sales (K Bottle) by Company (2016-2021)
Table 87. Southeast Asia Subcutaneous Immunoglobulins Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Subcutaneous Immunoglobulins Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Subcutaneous Immunoglobulins Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Subcutaneous Immunoglobulins Sales by Purity (2016-2021) & (K Bottle)
Table 91. Southeast Asia Subcutaneous Immunoglobulins Sales Market Share by Purity (2016-2021)
Table 92. Southeast Asia Subcutaneous Immunoglobulins Sales by Purity (2022-2027) & (K Bottle)
Table 93. Southeast Asia Subcutaneous Immunoglobulins Sales Market Share by Purity (2022-2027)
Table 94. Southeast Asia Subcutaneous Immunoglobulins Sales by Application (2016-2021) & (K Bottle)
Table 95. Southeast Asia Subcutaneous Immunoglobulins Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Subcutaneous Immunoglobulins Sales by Application (2022-2027) & (K Bottle)
Table 97. Southeast Asia Subcutaneous Immunoglobulins Sales Market Share by Application (2022-2027)
Table 98. India Subcutaneous Immunoglobulins Sales (K Bottle) by Company (2016-2021)
Table 99. India Subcutaneous Immunoglobulins Sales Market Share by Company (2016-2021)
Table 100. India Subcutaneous Immunoglobulins Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Subcutaneous Immunoglobulins Revenue Market Share by Company (2016-2021)
Table 102. India Subcutaneous Immunoglobulins Sales by Purity (2016-2021) & (K Bottle)
Table 103. India Subcutaneous Immunoglobulins Sales Market Share by Purity (2016-2021)
Table 104. India Subcutaneous Immunoglobulins Sales by Purity (2022-2027) & (K Bottle)
Table 105. India Subcutaneous Immunoglobulins Sales Market Share by Purity (2022-2027)
Table 106. India Subcutaneous Immunoglobulins Sales by Application (2016-2021) & (K Bottle)
Table 107. India Subcutaneous Immunoglobulins Sales Market Share by Application (2016-2021)
Table 108. India Subcutaneous Immunoglobulins Sales by Application (2022-2027) & (K Bottle)
Table 109. India Subcutaneous Immunoglobulins Sales Market Share by Application (2022-2027)
Table 110. Shire (Baxalta) Corporation Information
Table 111. Shire (Baxalta) Description and Business Overview
Table 112. Shire (Baxalta) Subcutaneous Immunoglobulins Sales (K Bottle), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 113. Shire (Baxalta) Subcutaneous Immunoglobulins Product
Table 114. Shire (Baxalta) Recent Development
Table 115. Grifols Corporation Information
Table 116. Grifols Description and Business Overview
Table 117. Grifols Subcutaneous Immunoglobulins Sales (K Bottle), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 118. Grifols Subcutaneous Immunoglobulins Product
Table 119. Grifols Recent Development
Table 120. CSL Corporation Information
Table 121. CSL Description and Business Overview
Table 122. CSL Subcutaneous Immunoglobulins Sales (K Bottle), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 123. CSL Subcutaneous Immunoglobulins Product
Table 124. CSL Recent Development
Table 125. Production Base and Market Concentration Rate of Raw Material
Table 126. Key Suppliers of Raw Materials
Table 127. Subcutaneous Immunoglobulins Distributors List
Table 128. Subcutaneous Immunoglobulins Customers List
Table 129. Subcutaneous Immunoglobulins Market Trends
Table 130. Subcutaneous Immunoglobulins Market Drivers
Table 131. Subcutaneous Immunoglobulins Market Challenges
Table 132. Subcutaneous Immunoglobulins Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Subcutaneous Immunoglobulins Product Picture
Figure 2. Global Subcutaneous Immunoglobulins Sales Market Share by Purity in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Subcutaneous Immunoglobulins Sales Market Share by Application in 2021 & 2027
Figure 6. Primary Immunodeficiency Examples
Figure 7. Secondary Immunodeficiency Examples
Figure 8. Others Examples
Figure 9. Global Subcutaneous Immunoglobulins Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Subcutaneous Immunoglobulins Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Subcutaneous Immunoglobulins Sales (K Bottle) Growth Rate (2016-2027)
Figure 12. Global Subcutaneous Immunoglobulins Price Trends Growth Rate (2016-2027) (USD/Bottle)
Figure 13. Global Subcutaneous Immunoglobulins Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Subcutaneous Immunoglobulins Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Subcutaneous Immunoglobulins Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Subcutaneous Immunoglobulins Sales (K Bottle) Growth Rate (2016-2027)
Figure 17. Europe Subcutaneous Immunoglobulins Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Subcutaneous Immunoglobulins Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Subcutaneous Immunoglobulins Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Subcutaneous Immunoglobulins Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Subcutaneous Immunoglobulins Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Subcutaneous Immunoglobulins Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Subcutaneous Immunoglobulins Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Subcutaneous Immunoglobulins Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Subcutaneous Immunoglobulins Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Subcutaneous Immunoglobulins Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Subcutaneous Immunoglobulins Players Market Share by Revenue in Subcutaneous Immunoglobulins: 2016 & 2020
Figure 28. Subcutaneous Immunoglobulins Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Subcutaneous Immunoglobulins Revenue Share by Purity (2016-2021)
Figure 30. Global Subcutaneous Immunoglobulins Revenue Growth Rate by Purity in 2016 & 2020
Figure 31. Global Subcutaneous Immunoglobulins Revenue Share by Application (2016-2021)
Figure 32. Global Subcutaneous Immunoglobulins Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Subcutaneous Immunoglobulins Sales Market Share by Purity in 2020
Figure 34. North America Subcutaneous Immunoglobulins Sales Market Share by Application in 2020
Figure 35. Europe Subcutaneous Immunoglobulins Sales Market Share by Purity in 2020
Figure 36. Europe Subcutaneous Immunoglobulins Sales Market Share by Application in 2020
Figure 37. China Subcutaneous Immunoglobulins Sales Market Share by Purity in 2020
Figure 38. China Subcutaneous Immunoglobulins Sales Market Share by Application in 2020
Figure 39. Japan Subcutaneous Immunoglobulins Sales Market Share by Purity in 2020
Figure 40. Japan Subcutaneous Immunoglobulins Sales Market Share by Application in 2020
Figure 41. Southeast Asia Subcutaneous Immunoglobulins Sales Market Share by Purity in 2020
Figure 42. Southeast Asia Subcutaneous Immunoglobulins Sales Market Share by Application in 2020
Figure 43. India Subcutaneous Immunoglobulins Sales Market Share by Purity in 2020
Figure 44. India Subcutaneous Immunoglobulins Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Subcutaneous Immunoglobulins
Figure 47. Manufacturing Process Analysis of Subcutaneous Immunoglobulins
Figure 48. Subcutaneous Immunoglobulins Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed

以下、関連資料のご紹介

トポテカン塩酸塩のグローバル市場2021

Global Topotecan Hydrochloride Sales Market Report 2021
QAF27910 2021年4月8日 139Pages
本市場調査資料では、世界のトポテカン塩酸塩市場について種類別（> 98％、≤98％）、用途別（注射、カプセル）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場...

高純度オルガノシリカゾルのグローバル市場2021

Global High Purity Organo Silica Sol Sales Market Report 2021
QAF25729 2021年4月21日 132Pages
本市場調査資料では、世界の高純度オルガノシリカゾル市場について種類別（10-15nm、40-50nm、70-100nm、その他）、用途別（電子分野、セラミックバインダー、ナノ複合材料、機能性樹脂、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2...

過免疫グロブリンのグローバル市場2021

Global Hyperimmune Globulins Sales Market Report 2021
QAF27729 2021年4月5日 140Pages
本市場調査資料では、世界の過免疫グロブリン市場について種類別（B型肝炎免疫グロブリン、狂犬病免疫グロブリン、破傷風免疫グロブリン、Rho（D）免疫グロブリン、その他）、用途別（政府機関、民間部門、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2...

高純度イソプロピルアルコール（IPA）のグローバル市場2021

Global High-purity Isopropyl Alcohol (IPA) Sales Market Report 2021
QAF21562 2021年3月31日 131Pages
本市場調査資料では、世界の高純度イソプロピルアルコール（IPA）市場について種類別（純度99.99％、純度<99.99％）、用途別（半導体、PCB、LCDクリーニング、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市...

高純度アルミニウムのグローバル市場2021

Global High Purity Aluminum Sales Market Report 2021
QAF21538 2021年3月31日 137Pages
本市場調査資料では、世界の高純度アルミニウム市場について種類別（4N、4N5、5N、その他）、用途別（電子工業、化学工業、高純度合金、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）...

チモキノンのグローバル市場2021

Global Thymoquinone Sales Market Report 2021
QAF27908 2021年3月23日 148Pages
本市場調査資料では、世界のチモキノン市場について種類別（純度：99％以上、純度：98％-99％、純度：98％以下）、用途別（医薬品、化学・材料）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格...

高純度アルミナのグローバル市場2021

Global High-purity Alumina Sales Market Report 2021
QAF21560 2021年4月2日 132Pages
本市場調査資料では、世界の高純度アルミナ市場について種類別（4N、4Nx、5N）、用途別（リチウムイオン電池、LED、半導体、蓄光剤、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）...

6-FDAのグローバル市場2021

Global 6-FDA (CAS 1107-00-2) Sales Market Report 2021
QAF23063 2021年4月16日 132Pages
本市場調査資料では、世界の6-FDA市場について種類別（99％純度6-FDA、99.5％純度6-FDA）、用途別（ポリイミドフィルム、フッ素化ポリイミド）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、...

ターゲット用高純度銅のグローバル市場2021

Global High Purity Copper for Targets Sales Market Report 2021
QAF21540 2021年4月26日 131Pages
本市場調査資料では、世界のターゲット用高純度銅市場について種類別（5N、6N、7N）、用途別（半導体、フラットパネルディスプレイ、太陽光発電）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）...

グリセロールフォーマルのグローバル市場2021

Global Glycerol Formal Sales Market Report 2021
QAF21465 2021年3月23日 137Pages
本市場調査資料では、世界のグリセロールフォーマル市場について種類別（純度99％、純度99.5％）、用途別（医薬品用、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの...

皮下ドラッグデリバリー機器のグローバル市場調査 2019年 The global Subcutaneous Drug Delivery Equipment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Subcutaneous Drug Delivery Equipment volume and value at global level, regional level and company leve…
皮下ドラッグデリバリー機器のグローバル市場調査 2019年 The global Subcutaneous Drug Delivery Equipment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Subcutaneous Drug Delivery Equipment volume and value at global level, regional level and company leve…
過免疫グロブリンのグローバル市場2021 Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, var…
世界のヒト免疫不全ウイルス (HIV) 治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Human Immunodeficiency Virus (HIV) Therapeutics Market The global Human Immunodeficiency Virus (HIV) Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accu…
スマトリプタンコハク酸塩のグローバル市場調査 2019年 The global Sumatriptan Succinate market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Sumatriptan Succinate volume and value at global level, regional level and company level. From a global perspective, …